These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22052930)

  • 1. Pulmonary microcirculation in interstitial lung disease.
    Farkas L; Kolb M
    Proc Am Thorac Soc; 2011 Nov; 8(6):516-21. PubMed ID: 22052930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
    Weitzenblum E; Chaouat A; Canuet M; Kessler R
    Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapies for interstitial lung disease: past, present and future.
    Kim R; Meyer KC
    Ther Adv Respir Dis; 2008 Oct; 2(5):319-38. PubMed ID: 19124380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial lung diseases in children: a review.
    Vangveeravong M; Schidlow DV
    J Med Assoc Thai; 1995 Mar; 78(3):145-56. PubMed ID: 7643031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphology, pathogenesis and classification of interstitial lung diseases].
    Strukov AI; Paukov VS; Orekhov OO
    Arkh Patol; 1984; 46(7):3-14. PubMed ID: 6383289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial lung disease: trials and tribulations.
    Afshar K; Sharma OP
    Curr Opin Pulm Med; 2008 Sep; 14(5):427-33. PubMed ID: 18664973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study.
    Gunnarsson R; Aaløkken TM; Molberg Ø; Lund MB; Mynarek GK; Lexberg AS; Time K; Dhainaut AS; Bertelsen LT; Palm O; Irgens K; Becker-Merok A; Nordeide JL; Johnsen V; Pedersen S; Prøven A; Garabet LS; Gran JT
    Ann Rheum Dis; 2012 Dec; 71(12):1966-72. PubMed ID: 22550317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary hypertension in COPD and interstitial lung diseases].
    Markart P; Ghofrani HA; Grimminger F; Günther A
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S164-6. PubMed ID: 19718606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of endothelial dysfunction and coagulation disorders in the development of pulmonary fibrosis in patients with interstitial lung diseases].
    Ppova EN; Arkhipova DV; Kozlovskaia LV; Privalova EV; Bitsadze VO; Kornev BM
    Klin Med (Mosk); 2004; 82(6):38-42. PubMed ID: 15344689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
    Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
    Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic options for systemic sclerosis related interstitial lung diseases.
    Mouthon L; Bérezné A; Guillevin L; Valeyre D
    Respir Med; 2010 Jul; 104 Suppl 1():S59-69. PubMed ID: 20630349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases.
    Fujiwara A; Kobayashi H; Masuya M; Maruyama M; Nakamura S; Ibata H; Fujimoto H; Ohnishi M; Urawa M; Naito M; Takagi T; Kobayashi T; Gabazza EC; Takei Y; Taguchi O
    Respirology; 2012 May; 17(4):693-8. PubMed ID: 22404428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohort.
    Chua F; Higton AM; Colebatch AN; O'Reilly K; Grubnic S; Vlahos I; Edwards CJ; Kiely PD
    Rheumatology (Oxford); 2012 Oct; 51(10):1870-6. PubMed ID: 22763991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interstitial lung disease in rheumatoid arthritis].
    Froidevaux-Janin S; Dudler J; Nicod LP; Lazor R
    Rev Med Suisse; 2011 Nov; 7(318):2272-7. PubMed ID: 22400361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship between cigarette smoking and some types of idiopathic interstitial pneumonias].
    Gasior G; Pierzchała W; Ograbek-Król M
    Wiad Lek; 2008; 61(1-3):48-52. PubMed ID: 18717043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary function tests.
    Behr J; Furst DE
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v65-7. PubMed ID: 18784151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial lung disease in systemic sclerosis: pathophysiology, current and new advances in therapy.
    Jain S; Shahane A; Derk CT
    Inflamm Allergy Drug Targets; 2012 Aug; 11(4):266-77. PubMed ID: 22506881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.